French biotech Ciloa outlines how 14 years of exosome engineering trials led to breakthrough adiponectin biotherapeutic now advancing toward Phase I trials in 2027. CEO Robert Z. Mamoun describes the transition from retrovirus research to developing what the company claims
Paris biotech One Biosciences outlines how single-cell transcriptomics can transform precision oncology by capturing the cellular complexity that traditional bulk sequencing misses. Founded by Institut Curie pioneer Dr. Céline Vallot, the company has secured over €20 million to bring OneMap™
Irish biotech Priothera is advancing mocravimod, a non-immunosuppressive S1P receptor modulator that the founding team rescued from Novartis’ pipeline, now targeting improved survival outcomes for AML patients undergoing stem cell transplantation. Co-founder Dr. Simone Seiter outlines how strategic protocol amendments
Swedish biotech Alligator Bioscience outlines how strategic antibody engineering and focused execution positioned mitazalimab for pivotal trials in metastatic pancreatic cancer, transforming from university research into a Phase 3-ready immunotherapy program. Founded in 2001 and headquartered in Lund, Sweden, Alligator
Addressing an Aggressive Pediatric Disease with No Treatment Options Spanish biotech Minoryx has carved out a critical position in orphan CNS diseases by developing leriglitazone for X-linked adrenoleukodystrophy (X-ALD), a genetic condition where patients in the most aggressive phenotype face
“When you are seeing great results in your research lab, you think that everything has been done. But then when you try to humanise your drug, a new adventure starts, because the CMC process is very difficult. In my opinion,
“There are not that many European CDMOs with commercial expertise in cell therapy – who understand the regulatory requirements and production challenges when you have to manufacture large quantities on a regular basis. This is why we ended up with
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
